Method for knocking out drug resistance gene mcr-1 through CRISPR-Cas9 in vitro and specialized cell penetrating peptide thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
- Publication Date
- 2017-03-29
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of microbial genetic engineering and biotechnology, in particular to a method for knocking out microbial drug resistance gene mcr-1 in vitro using a CRISPR-Cas9 system and its special cell-penetrating peptide CPP5a. Background technique
[0002] Professor Liu Jianhua of South China Agricultural University and Professor Shen Jianzhong of China Agricultural University found a new gene mcr-1 of polymyxin resistance in animals and hospitalized patients (Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, SpencerJ, Doi Y , Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasma-mediated colistin resistance mechanism MCR -1 in animals and human beings in China: amicrobiological and molecular biological study. Lancet Infect Dis 16:161-168.) This gene is carried by a plasmid and can be transferred horizontally between different strains. Before the publication of this d...